U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study

BackgroundSerum uric acid (SUA) interferes with lipid metabolism and is considered an independent risk factor for atherosclerosis, a major complication in patients with hyperlipidemia. However, the effects of uric acid levels on mortality in hyperlipidemic patients has yet to be sufficiently determi...

Full description

Bibliographic Details
Main Authors: Lihua Huang, Zhanpeng Lu, Xiaoyan You, Chunsheng Zou, Liuliu He, Jingxiang Xie, Xiaoqing Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1165338/full
_version_ 1797821834122493952
author Lihua Huang
Zhanpeng Lu
Xiaoyan You
Chunsheng Zou
Liuliu He
Jingxiang Xie
Xiaoqing Zhou
author_facet Lihua Huang
Zhanpeng Lu
Xiaoyan You
Chunsheng Zou
Liuliu He
Jingxiang Xie
Xiaoqing Zhou
author_sort Lihua Huang
collection DOAJ
description BackgroundSerum uric acid (SUA) interferes with lipid metabolism and is considered an independent risk factor for atherosclerosis, a major complication in patients with hyperlipidemia. However, the effects of uric acid levels on mortality in hyperlipidemic patients has yet to be sufficiently determined. In this study, we aimed to assess the association between all-cause mortality and SUA in a hyperlipidemic population.MethodsTo determine mortality rates, we obtained data for 20,038 hyperlipidemia patients from the U.S. National Health and Nutrition Examination Surveys (NHANES) 2001–2018 and National Death Index. To examine the all-cause mortality effect of SUA, multivariable Cox regression models, restricted cubic spline models, and two pairwise Cox regression models were used.ResultsOver a median follow-up of 9.4 years, a total of 2079 deaths occurred. Mortality was examined according to SUA level quintiles: <4.2, 4.3–4.9, 5.0–5.7, 5.8–6.5, and >6.6 mg/dl. In multivariable analysis using 5.8–6.5 mg/dl SUA as a reference, the hazard ratios (95% confidence interval) of all-cause mortality across the five groups were 1.24 (1.06–1.45), 1.19 (1.03–1.38), 1.07 (0.94–1.23), 1.00 (reference), and 1.29 (1.13–1.48), respectively. According to a restricted cubic spline, we noted a U-shaped relationship between SUA and all-cause mortality. The inflection point was approximately 6.30 mg/dl, with hazard ratios of 0.91 (0.85–0.97) and 1.22 (1.10–1.35) to the left and right of the inflection point, respectively. In both sexes, SUA was characterized by a U-shaped association, with inflection points at 6.5 and 6.0 mg/dl for males and females, respectively.ConclusionUsing nationally representative NHANES data, we identified a U-shaped association between SUA and all-cause mortality in participants with hyperlipidemia.
first_indexed 2024-03-13T09:58:46Z
format Article
id doaj.art-7c44d27679124ceca89f1cc8c3ce3bd1
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-13T09:58:46Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-7c44d27679124ceca89f1cc8c3ce3bd12023-05-23T10:55:02ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-05-011010.3389/fcvm.2023.11653381165338U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort studyLihua Huang0Zhanpeng Lu1Xiaoyan You2Chunsheng Zou3Liuliu He4Jingxiang Xie5Xiaoqing Zhou6Department of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaDepartment of Critical Care, The Eighth Affiliated Hospital of Sun Yat sen University, Shenzhen, ChinaDepartment of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaDepartment of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaDepartment of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaDepartment of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaGeneral Surgery Department, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, ChinaBackgroundSerum uric acid (SUA) interferes with lipid metabolism and is considered an independent risk factor for atherosclerosis, a major complication in patients with hyperlipidemia. However, the effects of uric acid levels on mortality in hyperlipidemic patients has yet to be sufficiently determined. In this study, we aimed to assess the association between all-cause mortality and SUA in a hyperlipidemic population.MethodsTo determine mortality rates, we obtained data for 20,038 hyperlipidemia patients from the U.S. National Health and Nutrition Examination Surveys (NHANES) 2001–2018 and National Death Index. To examine the all-cause mortality effect of SUA, multivariable Cox regression models, restricted cubic spline models, and two pairwise Cox regression models were used.ResultsOver a median follow-up of 9.4 years, a total of 2079 deaths occurred. Mortality was examined according to SUA level quintiles: <4.2, 4.3–4.9, 5.0–5.7, 5.8–6.5, and >6.6 mg/dl. In multivariable analysis using 5.8–6.5 mg/dl SUA as a reference, the hazard ratios (95% confidence interval) of all-cause mortality across the five groups were 1.24 (1.06–1.45), 1.19 (1.03–1.38), 1.07 (0.94–1.23), 1.00 (reference), and 1.29 (1.13–1.48), respectively. According to a restricted cubic spline, we noted a U-shaped relationship between SUA and all-cause mortality. The inflection point was approximately 6.30 mg/dl, with hazard ratios of 0.91 (0.85–0.97) and 1.22 (1.10–1.35) to the left and right of the inflection point, respectively. In both sexes, SUA was characterized by a U-shaped association, with inflection points at 6.5 and 6.0 mg/dl for males and females, respectively.ConclusionUsing nationally representative NHANES data, we identified a U-shaped association between SUA and all-cause mortality in participants with hyperlipidemia.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1165338/fulluric acidhyperlipidemiaNHANESmortalityU-shaped
spellingShingle Lihua Huang
Zhanpeng Lu
Xiaoyan You
Chunsheng Zou
Liuliu He
Jingxiang Xie
Xiaoqing Zhou
U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
Frontiers in Cardiovascular Medicine
uric acid
hyperlipidemia
NHANES
mortality
U-shaped
title U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
title_full U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
title_fullStr U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
title_full_unstemmed U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
title_short U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
title_sort u shaped association of serum uric acid with all cause mortality in patients with hyperlipidemia in the united states a cohort study
topic uric acid
hyperlipidemia
NHANES
mortality
U-shaped
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1165338/full
work_keys_str_mv AT lihuahuang ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT zhanpenglu ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT xiaoyanyou ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT chunshengzou ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT liuliuhe ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT jingxiangxie ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy
AT xiaoqingzhou ushapedassociationofserumuricacidwithallcausemortalityinpatientswithhyperlipidemiaintheunitedstatesacohortstudy